Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection

Por Hraber, Peter, Seaman, Michael S., Bailer, Robert T., Mascola, John R., Montefiori, David C., Korber, Bette T.
Publicado em 2014

Toxicological Safety Evaluation of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar Despite Differing Plasmid Backbones o...

Por Sheets, Rebecca L., Stein, Judith, Manetz, T. Scott, Andrews, Charla, Bailer, Robert, Rathmann, John, Gomez, Phillip L.
Publicado em 2006

Systemic and Mucosal T-Lymphocyte Activation Induced by Recombinant Adenovirus Vaccines in Rhesus Monkeys

Por Sun, Yue, Bailer, Robert T., Rao, Srinivas S., Mascola, John R., Nabel, Gary J., Koup, Richard A., Letvin, Norman L.
Publicado em 2009

Persistent memory CD4(+) and CD8(+) T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen

Por Yang, Litao, Peng, Hui, Zhu, Zhaoling, Li, Gang, Huang, Zitong, Zhao, Zhixin, Koup, Richard A., Bailer, Robert T., Wu, Changyou
Publicado em 2007

Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection

Por Fan, Yan-Ying, Huang, Zi-Tong, Li, Li, Wu, Man-Hui, Yu, Tao, Koup, Richard A., Bailer, Robert T., Wu, Chang-You
Publicado em 2009

Live Adenovirus Type 4 Recombinants Induce Durable Neutralizing Antibody Responses to Influenza H5 with High Levels of Somatic Hypermutation in Humans

Por Huang, Jinghe, Kang, Byong, Wheatley, Adam, Narpala, Sandeep, Mcdermott, Adrian, Poole, April, Bailer, Robert, Koup, Richard, Migueles, Stephen, Gurwith, Marc, Connors, Mark
Publicado no AIDS Res Hum Retroviruses (2014)

Replication-Defective Adenovirus Vectors with Multiple Deletions Do Not Induce Measurable Vector-Specific T Cells in Human Trials

Por Koup, Richard A., Lamoreaux, Laurie, Zarkowsky, David, Bailer, Robert T., King, C. Richter, Gall, Jason G. D., Brough, Douglas E., Graham, Barney S., Roederer, Mario
Publicado em 2009

Adenovirus Type 4 and 7 Vaccination or Adenovirus Type 4 Respiratory Infection Elicits Minimal Cross-Reactive Antibody Responses to Nonhuman Adenovirus Vaccine Vectors

Por Paris, Robert, Kuschner, Robert A., Binn, Leonard, Thomas, Stephen J., Colloca, Stefano, Nicosia, Alfredo, Cortese, Riccardo, Bailer, Robert T., Sullivan, Nancy, Koup, Richard A.
Publicado em 2014

Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults

Por Huang, Yunda, Zhang, Lily, Ledgerwood, Julie, Grunenberg, Nicole, Bailer, Robert, Isaacs, Abby, Seaton, Kelly, Mayer, Kenneth H., Capparelli, Edmund, Corey, Larry, Gilbert, Peter B.
Publicado no MAbs (2017)

Biodistribution and Toxicological Safety of Adenovirus Type 5 and Type 35 Vectored Vaccines Against Human Immunodeficiency Virus-1 (HIV-1), Ebola, or Marburg Are Similar Despite Di...

Por Sheets, Rebecca L., Stein, Judith, Bailer, Robert T., Koup, Richard A., Andrews, Charla, Nason, Martha, He, Bin, Koo, Edward, Trotter, Holly, Duffy, Chris, Manetz, T. Scott, Gomez, Phillip
Publicado em 2008

HIV-1 Neutralization Coverage Is Improved by Combining Monoclonal Antibodies That Target Independent Epitopes

Por Doria-Rose, Nicole A., Louder, Mark K., Yang, Zhongjia, O'Dell, Sijy, Nason, Martha, Schmidt, Stephen D., McKee, Krisha, Seaman, Michael S., Bailer, Robert T., Mascola, John R.
Publicado em 2012

A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling

Por Imholte, Greg C., Sauteraud, Renan, Korber, Bette, Bailer, Robert T., Turk, Ellen T., Shen, Xiaoying, Tomaras, Georgia D., Mascola, John R., Koup, Richard A., Montefiori, David C., Gottardo, Raphael
Publicado em 2013

Isolation of human monoclonal antibodies from peripheral blood B cells

Por Huang, Jinghe, Doria-Rose, Nicole A, Longo, Nancy S, Laub, Leo, Lin, Chien-Li, Turk, Ellen, Kang, Byong H, Migueles, Stephen A, Bailer, Robert T, Mascola, John R, Connors, Mark
Publicado no Nat Protoc (2013)

Optimization and Validation of the TZM-bl Assay for Standardized Assessments of Neutralizing Antibodies Against HIV-1

Por Sarzotti-Kelsoe, Marcella, Bailer, Robert T, Turk, Ellen, Lin, Chen-li, Bilska, Miroslawa, Greene, Kelli M., Gao, Hongmei, Todd, Christopher A., Ozaki, Daniel A., Seaman, Michael S., Mascola, John R., Montefiori, David C.
Publicado em 2013

Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011)

Por Enama, Mary E., Ledgerwood, Julie E., Novik, Laura, Nason, Martha C., Gordon, Ingelise J., Holman, LaSonji, Bailer, Robert T., Roederer, Mario, Koup, Richard A., Mascola, John R., Nabel, Gary J., Graham, Barney S.
Publicado em 2014

Safety, Immunogenicity and Efficacy of Modified Vaccinia Ankara (MVA) Against Dryvax(®) Challenge in Vaccinia-Naïve and Vaccinia-Immune Individuals

Por Parrino, Janie, McCurdy, Lewis H., Larkin, Brenda D., Gordon, Ingelise J., Rucker, Steven E., Enama, Mary E., Koup, Richard A., Roederer, Mario, Bailer, Robert T., Moodie, Zoe, Gu, Lin, Yan, Lihan, Graham, Barney S.
Publicado em 2006

Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses

Por Koup, Richard A., Roederer, Mario, Lamoreaux, Laurie, Fischer, Jennifer, Novik, Laura, Nason, Martha C., Larkin, Brenda D., Enama, Mary E., Ledgerwood, Julie E., Bailer, Robert T., Mascola, John R., Nabel, Gary J., Graham, Barney S.
Publicado em 2010

DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial

Por Graham, Barney S., Enama, Mary E., Nason, Martha C., Gordon, Ingelise J., Peel, Sheila A., Ledgerwood, Julie E., Plummer, Sarah A., Mascola, John R., Bailer, Robert T., Roederer, Mario, Koup, Richard A., Nabel, Gary J.
Publicado em 2013

Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect

Por Ledgerwood, Julie E., Zephir, Kathryn, Hu, Zonghui, Wei, Chih-Jen, Chang, LeeJah, Enama, Mary E., Hendel, Cynthia S., Sitar, Sandra, Bailer, Robert T., Koup, Richard A., Mascola, John R., Nabel, Gary J., Graham, Barney S.
Publicado em 2013

Homologous Boosting with Adenoviral Serotype 5 HIV Vaccine (rAd5) Vector Can Boost Antibody Responses despite Preexisting Vector-Specific Immunity in a Randomized Phase I Clinical...

Por Sarwar, Uzma N., Novik, Laura, Enama, Mary E., Plummer, Sarah A., Koup, Richard A., Nason, Martha C., Bailer, Robert T., McDermott, Adrian B., Roederer, Mario, Mascola, John R., Ledgerwood, Julie E., Graham, Barney S.
Publicado em 2014